|
2005 News Releases
MEDICURE ANNOUNCES BOUGHT DEAL FINANCING
December 12, 2005
A MICHAEL LINCOFF JOINS MEDICURE'S SCIENTIFIC ADVISORY BOARD
December 7, 2005
MEDICURE REPORTS POSITIVE RESULTS FROM THE PHASE II MEND-CABG STUDY
December 5, 2005
MEDICURE ANNOUNCES PLANS TO RELEASE RESULTS FROM THE MEND-CABG STUDY
December 2, 2005
PETER QUICK APPOINTED TO MEDICURE BOARD OF DIRECTORS
November 28, 2005
MEDICURE'S MC-1 HIGHLIGHTED IN PEER REVIEWED SCIENTIFIC JOURNAL
November 23, 2005
MEDICURE TO PRESENT AT BIOTECH INVESTOR CONFERENCE
November 3, 2005
MEDICURE TO WEBCAST 2005 ANNUAL AND SPECIAL MEETING
October 24, 2005
MEDICURE ANNOUNCES FINANCIAL RESULTS FOR FISCAL FIRST QUARTER 2006
October 13, 2005
MEDICURE TO PRESENT AT BIOTECH INVESTOR CONFERENCES
October 3, 2005
FDA GRANTS MC-1 FAST TRACK DESIGNATION
September 21, 2005
MEDICURE MEETS PRIMARY ENDPOINTS IN PHASE II DIABETIC HYPERTENSION STUDY
September 14, 2005
MEDICURE TO HOST CONFERENCE CALL TO DISCUSS PHASE II MATCHED RESULTS
September 13, 2005
MEDICURE ADOPTS SHAREHOLDER RIGHTS PLAN
August 25, 2005
MEDICURE ANNOUNCES FISCAL 2005 FINANCIAL RESULTS
August 24, 2005
MEDICURE COMPLETES US$3.85 MILLION PRIVATE PLACEMENT
August 22, 2005
MEDICURE'S ANTITHROMBOTIC PROGRAM TO BE HIGHLIGHTED AT THE INTERNATIONAL SOCIETY OF THROMBOSIS & HAEMOSTASIS MEETING
July 18, 2005
MEDICURE COMPLETES PATIENT TREATMENT IN THE PHASE II MATCHED STUDY
July 14, 2005
MEDICURE COMPLETES ENROLLMENT IN MEND-CABG TRIAL
July 12, 2005
MEDICURE ANNOUNCES CHANGE IN BOARD
June 30, 2005
MEDICURE ANNOUNCES SUCCESSFUL NSERC GRANT APPLICATION
June 27, 2005
MEDICURE TO PRESENT AT BIO 2005
June 17, 2005
MEDICURE TO HOST ANALYST DAY
June 3, 2005
MEDICURE EXPANDS U.S. INTELLECTUAL PROPERTY PORTFOLIO
June 2, 2005
MEDICURE TO PRESENT AT BIOTECH CONFERENCES
May 16, 2005
MEDICURE ANNOUNCES POSITIVE PRECLINICAL RESULTS FOR MC-1
May 5, 2005
MEDICURE TO PRESENT AT RODMAN & RENSHAW GLOBAL HEALTHCARE CONFERENCE
May 2, 2005
MEDICURE ANNOUNCES SUCCESSFUL DSMB REVIEW FROM ONGOING PHASE II/III MEND-CABG TRIAL
April 19, 2005
MEDICURE TO PRESENT AT EUROPEAN BIOTECH CONFERENCES
April 12, 2005
MEDICURE RECEIVES PATENT FOR THE TREATMENT OF STROKE
April 8, 2005
MEDICURE ANNOUNCES FINANCIAL RESULTS FOR FISCAL THIRD QUARTER 2005
April 5, 2005
MEDICURE EXPANDS INTELLECTUAL
PATENT PORTFOLIO
March 29, 2005
MEDICURE UNVEILS ENHANCED WEBSITE AND
NEW DOMAIN NAME - www.medicure.com
March 7, 2005
MEDICURE ANNOUNCES FULL PATIENT ENROLLMENT IN ITS PHASE II
MATCHED CLINICAL TRIAL
March 1, 2005
MEDICURE REPORTS POSITIVE PRECLINICAL RESULTS FOR NOVEL
ANTITHROMBOTIC, MC-45308
February 28, 2005
MEDICURE TO PARTICIPATE IN CARDIOVASCULAR PANEL AT BIO CEO CONFERENCE IN NEW YORK
February 21, 2005
MEDICURE ACQUIRES NOVEL CHOLESTEROL LOWERING TECHNOLOGY PLATFORM
January 31, 2005
MEDICURE CEO TO CHAIR ROUNDTABLE DISCUSSION AT MAJOR BIOTECH CONFERENCE
January 26, 2005
MEDICURE TO PRESENT LATEST FINDINGS AT PRESTIGIOUS EUROPEAN SCIENTIFIC MEETING
January 25, 2005
MEDICURE ANNOUNCES FINANCIAL RESULTS FOR FISCAL SECOND QUARTER
January 13, 2005
|
Management Team 
Analyst Coverage 
